Alx Oncology Holdings Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$2.04

+0.01 (+0.49%)

As of May 16, 2:12 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 11 85%

Hold 2 15%

Sell 0 0%

Price Target

Analyst Price Target +1,161.3% upside

Low Target $15.89

Average Target $25.73

High Target $34.39

Current Price $2.04

Current
$2.04

Target
$25.73

$15.89 $25.73 avg $34.39

Scenario Analysis

Bear Case

$15.89

678.9%

Low target

Base Case

$25.73

+1,161.3%

Avg target

Bull Case

$34.39

+1,585.8%

High target

Risk/Reward

2.3x

Favorable

Price in Context

52-Week High

$2.66

-23.3% from high

52-Week Low

$0.40

+405.0% from low

Target vs 52W High

$25.73

+867.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%